Full article view2018-07-17T08:45:50+00:00
Back to News & Insights »

Innovations in Cancer Care: Capturing What Patients Value in the Calculus of Drug Costs

As healthcare spending continues to rise, payers and providers struggle to accurately measure value to patients, and with health systems all over the world shifting towards paying for value, not just volume, these efforts have never been more important. This research brief shares novel, groundbreaking studies that have helped define the value of new oncology drugs, and recommends new criteria for framing value in cancer care.

Get the brief
[contact-form-7 id="" title=""]

    Precision Medicine Group is an integrated team of experts in fields from advanced lab sciences to translational informatics and regulatory affairs, payer insights to marketing communications. Together, we help our pharmaceutical and life-sciences clients conquer product development and commercialization challenges in a rapidly evolving environment.

    By continuing to use our website, you agree to our use of cookies to help us give you the best experience, analyze your site usage, and assist in our marketing efforts.
    For more information, or to learn how to change your cookies preferences, please click here.

    OK